GSKGSK plc

NYSE gsk.com


$ 45.15 $ 0.10 (0.22 %)    

Monday, 13-May-2024 15:59:57 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 45.17
$ 45.33
$ 0.00 x 0
$ 0.00 x 0
$ 45.14 - $ 45.40
$ 32.35 - $ 45.41
2,472,890
na
97.39B
$ 0.53
$ 15.51
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV infection in at-risk adults and adoles...

 amazon-pours-13b-investment-into-french-operations-report

Amazon's €1.2 billion investment marks a significant stride in bolstering its French presence, promising 3,000 new jobs. Th...

 fda-delays-important-moderna-vaccine-review-william-blair-says-2025-growth-2026-breakeven-story-depends-on-it

FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

 pfizer-agrees-to-settle-over-10000-lawsuits-about-cancer-risks-associated-with-discontinued-heartburn-drug-zantac

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+...

 bioversys-and-gsk-boost-fight-against-tuberculosis-with-expanded-partnership-and-series-c-funding-increase-by-chf-123m

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis ...

 gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...

 wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-relief-why-this-analyst-sees-incoming-summer-rally

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc...

 gsk-q1-adj-eps-109-beats-091-estimate-sales-933b-beat-892b-estimate

GSK (NYSE:GSK) reported quarterly adjusted earnings of $1.09 per share which beat the analyst consensus estimate of $0.91 by 20...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

 whats-going-on-with-pfizer-stock-on-thursday

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

Core News & Articles

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

Core News & Articles

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next pha...

Core News & Articles

- Bloomberg

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION